These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31133437)

  • 1. Impact of Socioeconomic Status on Incidence of End-Stage Renal Disease and Mortality After Dialysis in Adults With Diabetes.
    Ke C; Kim SJ; Shah BR; Bierman AS; Lipscombe LL; Feig DS; Booth GL
    Can J Diabetes; 2019 Oct; 43(7):483-489.e4. PubMed ID: 31133437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low socio-economic status adversely effects dialysis survival in Australia.
    Krishnasamy R; Gray NA
    Nephrology (Carlton); 2018 May; 23(5):453-460. PubMed ID: 28383177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.
    Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of socioeconomic status on patient survival on chronic dialysis.
    Ward FL; O'Kelly P; Donohue F; O'Haiseadha C; Haase T; Pratschke J; deFreitas DG; Johnson H; O'Seaghdha CM; Conlon PJ
    Hemodial Int; 2015 Oct; 19(4):601-8. PubMed ID: 25854991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada.
    Rabbat CG; Thorpe KE; Russell JD; Churchill DN
    J Am Soc Nephrol; 2000 May; 11(5):917-922. PubMed ID: 10770970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.
    Hruskova Z; Pippias M; Stel VS; Abad-Díez JM; Benítez Sánchez M; Caskey FJ; Collart F; De Meester J; Finne P; Heaf JG; Magaz A; Palsson R; Reisæter AV; Salama AD; Segelmark M; Traynor JP; Massy ZA; Jager KJ; Tesar V
    Am J Kidney Dis; 2019 Feb; 73(2):184-193. PubMed ID: 30122544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany.
    Hoffmann F; Haastert B; Koch M; Giani G; Glaeske G; Icks A
    Nephrol Dial Transplant; 2011 May; 26(5):1634-40. PubMed ID: 20959344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic Status and Kidney Transplant Outcomes in a Universal Healthcare System: A Population-based Cohort Study.
    Naylor KL; Knoll GA; Shariff SZ; McArthur E; Garg AX; Van Walraven C; Austin PC; McCallum MK; Quinn RR; Tan VS; Kim SJ
    Transplantation; 2019 May; 103(5):1024-1035. PubMed ID: 30247444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis.
    Rhee CM; Kovesdy CP; You AS; Sim JJ; Soohoo M; Streja E; Molnar MZ; Amin AN; Abbott K; Nguyen DV; Kalantar-Zadeh K
    Am J Kidney Dis; 2018 Nov; 72(5):701-710. PubMed ID: 30037725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic status and the incidence of ESRD.
    Ward MM
    Am J Kidney Dis; 2008 Apr; 51(4):563-72. PubMed ID: 18371532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease.
    Rimes-Stigare C; Frumento P; Bottai M; Mårtensson J; Martling CR; Bell M
    Crit Care; 2015 Nov; 19():383. PubMed ID: 26526622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
    Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
    JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal Drug Coverage and Socioeconomic Disparities in Health Care Costs Among Persons With Diabetes.
    Isaranuwatchai W; Fazli GS; Bierman AS; Lipscombe LL; Mitsakakis N; Shah BR; Wu CF; Johns A; Booth GL
    Diabetes Care; 2020 Sep; 43(9):2098-2105. PubMed ID: 32641377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death and renal transplantation among Aboriginal people undergoing dialysis.
    Tonelli M; Hemmelgarn B; Manns B; Pylypchuk G; Bohm C; Yeates K; Gourishankar S; Gill JS
    CMAJ; 2004 Sep; 171(6):577-82. PubMed ID: 15367459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of socioeconomic status on stage at presentation, receipt of diagnostic imaging, receipt of treatment and overall survival in colorectal cancer patients.
    Shah R; Chan KKW
    Int J Cancer; 2021 Sep; 149(5):1031-1043. PubMed ID: 33950515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of socioeconomic status and geographic remoteness on access to pre-emptive kidney transplantation and transplant outcomes among children.
    Francis A; Didsbury M; Lim WH; Kim S; White S; Craig JC; Wong G
    Pediatr Nephrol; 2016 Jun; 31(6):1011-9. PubMed ID: 26692022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in Access to Kidney Transplantation Across Renal Programs in Ontario, Canada.
    Naylor KL; Dixon SN; Garg AX; Kim SJ; Blake PG; Nesrallah GE; McCallum MK; D'Antonio C; Li AH; Knoll GA
    Am J Transplant; 2017 Jun; 17(6):1585-1593. PubMed ID: 28068455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.